Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Medium and high-dose FTY720-P also enhances the levels of TGF-β1
including vascular endothelial growth factor and platelet-activating factor
a naturally occurring chemical in the body that acts as both a stress hormone and neurotransmitter
3-b]pyridine-2-carboxamide
4 nM and 15 nM for VEGFR2
Ripretinib rmectin B1a Medium and high-dose FTY720-P alsoRipretinib (DCC 2618) is an orally bioavailable, selective KIT and PDGFRA switch control inhibitor. Ripretinib (DCC 2618) targets and binds to both wild type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild type and mutant forms. Ripretinib (DCC 2618) also inhibits multiple other kinase targets, such as
US$ 1549.00
US$ 3004.50
US$ 1252.00
US$ 59.95
US$ 2297.00
US$ 49.95
US$ 69.95
US$ 1101.00